Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004640139 | SCV005133048 | uncertain significance | not specified | 2024-04-20 | criteria provided, single submitter | clinical testing | The c.955G>A (p.G319S) alteration is located in exon 5 (coding exon 3) of the LRTM2 gene. This alteration results from a G to A substitution at nucleotide position 955, causing the glycine (G) at amino acid position 319 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |